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Symptoms could include:
• Breathlessness
• Orthopnea
• Paroxysmal nocturnal dyspnea
• Fatigue
• Reduced exercise tolerance
• Nocturnal cough 
• Palpitations
• Bloated feeling
• Wheezing
Overall General Symptoms:
• Confusion 
• Depression
• Pain 
• Loss of appetite
Notation of all symptoms and 
description of variations from normal
routine essential to note to healthcare
provider to ensure the correct
diagnosis
Management of symptoms relies
largely on management of symptoms 
paired with patient’s co-morbidities. 
Co-morbidity examples could include:
• hypertension
• diabetes
• lung diseases
60% of elderly heart failure patients 
have at least three major comorbidities 
(Jung,Yeh, & Pressler, 2012).
Signs could include:
• Elevated jugular venous pressure
• Third heart sound
• Laterally displaced apex beat
• Tachycardia
• Irregular pulse
• Murmur
• Tachypnea
• Weight gain or loss
• Cold extremities
• Peripheral oedema
• Results from the heart failing to 
pump blood appropriately and 
cannot meet oxygen requirements 
for the rest of the body
• Affects almost six million 
Americans
• Leading cause of hospitalizations 
for patients older than 65 years
• Requires more hospitalization 
than any type of cancer
• Affects roughly two percent of the 
American population, and 
continues to be the most rapidly 
growing cardiac disease in the 
country (Parikh & Kadowitz, 
2013).
• The New York Heart Association 
(NYHA) and the American College 
of Cardiology with the American 
Heart Association (ACC/AHA) 
have provided classifications for 
the stages and levels of heart 
failure (See Table 1).
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New York Heart Association (NYHA)
American College of Cardiology/American Heart Association 
(ACC/AHA)
Class 1
Participates in activity 
without limitation
Stage A
Patients at risk for heart 
failure who have not yet 
developed structural heart 
changes
Class 2
Participates in activity with 
slight limitation
Stage B
Patients with structural 
heart disease who have not 
yet developed symptoms of 
heart failure
Class 3
Participates in activity with 
marked limitation
Stage C
Patients who have 
developed clinical heart 
failure
Class 4
Experience symptoms at 
rest, unable to take part in 
activity
Stage D
Patients with refractory 
heart failure requiring 
advanced intervention
Table 1. Heart Failure Classifications • Multi-disciplinary and multimodal treatment
• Individualized plan of care, use of medication, diet changes, smoking cessation, 
pharmacological therapy, weight loss, and behavior changes
• Main goal is to improve quality of life, increase longevity, and reduce 
cardiovascular and respiratory complications
• Treatment varies between non-pharmacologic methods, pharmacologic 
strategies, and may include the use of invasive therapies
Pharmacologic therapy could include:
• angiotensin-converting-enzyme inhibitor (ACE)
• aldosterone receptor blocker (ARB)
• vasodilators
• beta-blockers
• aldosterone antagonists
• diuretics
• anticoagulants
Other interventions could include:
• sodium and fluid restriction
• patient focused physical activity
• weight control
Use of invasive therapies include:
• pacemakers
• implanted-cardioverter-defibrillators
• resynchronization therapy
• coronary artery bypass grafts
• heart transplants
Implications for Nursing Care
Our Aging Population and the Rising Numbers 
of Congestive Heart Failure Diagnoses 
The care of a heart failure patient can be complicated and diverse. Not every patient will 
react to the exact course of treatment each time. Nursing care would initially attempt to 
educate the patient on non-pharmacologic treatment to reduce symptoms and improve 
lifestyle choices. This would require diet education, education toward appropriate 
physical activity and limitation, and the importance of weight monitoring.
In conclusion, as noted in the above breakdown, heart failure is a complex condition 
often requiring changes to lifestyle and frequent monitoring. It is often associated with 
high rates of morbidity and mortality. Mental health issues may arise as physical 
symptoms change or worsen. The provider role helps to ensure patients are provided 
with quality information and adequate support directed toward their condition.  The 
provider also plays a key role in recognizing mental health needs in conjunction with 
physical symptoms. Understanding the underlying symptoms, pathophysiology, and 
treatment options helps to ensure the promotion of evidenced-based informative 
practice and excellent care. 
Underlying Pathophysiology and Significance
Since this topic is of growing concern, and as our population ages, healthcare will 
continue to experience more patients experiencing heart failure as a condition. As 
clinicians manage patients with this condition, they will also have to consider the 
numerous other health factors and comorbidities that can affect the way in which each 
patient is provided care .
Especially important for use of current standards of practice with evidence-based 
practice approaches.
• Heart fails to pump blood 
appropriately, unable to meet 
oxygen needs for body
• Body attempts to compensate 
for impending failure by 
attempting to increase blood 
volume, increase cardiac 
filling, pressure, and 
increasing heart rate
• Eventually the heart loses the 
ability to adequately contract 
and relax, resulting in heart 
failure
• Dysfunction can easily lead to 
impaired airway clearance
• May experience the inability 
to sustain adequate 
ventilation during exertion or 
physical activity
• Shallow breathing limits
alveolar ventilation and 
diminishes gas exchange, and 
sympathetic activation causes 
cardiac arrhythmias and 
tissue vasoconstriction
• CHF can disrupt the balance
of cytokines and angiotensin
II, cell signals, reactive 
oxygen species, and 
proteolytic pathways
• The renin-angiotensin system 
is hyperactive
• Sympathetic nerve 
stimulation causes release of 
norepinephrine, which then 
results in smooth muscle 
activation and 
vasoconstriction. The heart 
rate is then increased and 
peripheral vascular 
resistance is noted
• The noted changes in the
renin-angiotensin-
aldosterone system is what
effects the blood pressure 
and the maintenance of 
electrolyte balance
• The stimulation of
angiotensin II stimulates 
release of aldosterone, which 
then increases fluid retention 
and blood pressure (Brake & 
Jones, 2017)
Figure 1. Pulmonary Oedema
Figure 1. CHF Signs/Symptoms
